{
  "catalogId": "7bab1501-6ed7-454e-9ef2-c9174645e5ad",
  "name": "TRUXIMA",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "161 74 35585 00",
  "treatmentDescriptions": "Truxima is indicated in adults for the following indications: * Non-Hodgkin’s lymphoma (NHL) Truxima is indicated for the treatment of patients with relapsed or refractory low-grade or follicular, B-cell non-hodgkin’s lymphoma. Truxima is indicated for the treatment of previously untreated patients with low-grade or follicular lymphoma in combination with chemotherapy. Truxima is indicated for the treatment of patients with CD20 positive diffuse large B-cell non-Hodgkin's lymphoma in combination with CHOP chemotherapy. Truxima maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy.* Chronic lymphocytic leukaemia (CLL)Truxima in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory CLL. Only limited data are available on efficacy and safety for patients previously treated with monoclonal antibodies including rituximab or patients refractory to previous rituximab plus chemotherapy.* Granulomatosis with polyangiitis and microscopic polyangiitisTruxima, in combination with glucocorticoids, is indicated for the treatment of adult patients with granulomatosis with polyangiitis (GPA)  (Wegener’s Granulomatosis (WG)) and microscopic polyangiitis (MPA).*pemphigus vulgaris (PV):Truxima is indicated for the treatment of adult patients with moderate to severe pemphigus vulgaris (PV).",
  "termsOfIssue": "Prescription required",
  "form": "concentrate for solution for infusion",
  "route": "i.v",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "RITUXIMAB/ML",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L01XC02",
      "name": "RITUXIMAB"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "TRUXIMA 500MG/50 ML 1 VIAL",
      "manufacturer": {
        "name": "פאדאגיס",
        "countryOfOrigin": "IL"
      },
      "strength": [
        {
          "value": 500.0,
          "unit": "mg"
        },
        {
          "value": 50.0,
          "unit": "ml"
        },
        {
          "value": 50.0,
          "unit": "ml"
        }
      ],
      "quantity": {
        "value": 1.0,
        "unit": "units"
      },
      "packagingDescription": "VIAL 10 ML GLASS TYPE I",
      "shelfLife": "48",
      "storageConditions": "",
      "codes": {
        "moh": "8343",
        "yarpa": "30893",
        "pharmasoft": "20865",
        "barcode": "7290012162404"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 3020.062306,
        "retailMargin": 10.0,
        "maxRetailPrice": 3322.068537,
        "maxPriceWithVAT": 3920.040699
      },
      "formulation": ""
    }
  ],
  "metadata": {
    "version": "1.5",
    "lastUpdated": "2025-08-01T18:03:51.100584",
    "tags": [
      "needs_manual_review"
    ],
    "availableApiOptions": [
      {
        "name": "TRUXIMA",
        "registration": "161 74 35585 00",
        "form": ""
      }
    ],
    "smartValidation": {
      "extractedFrom": "TRUXIMA 500MG/50 ML 1 VIAL",
      "processedBy": "smart_validation",
      "bestMatchScore": 0.008333333333333333,
      "status": "failed_match"
    }
  }
}